May 18

Ensuring Diversity and Inclusion in Clinical TrialsWednesday, 18 May 2022 - EST (Eastern Standard Time, GMT-5)

8:00am - 8:05am5 mins

Ensuring Diversity and Inclusion in Clinical Trials

Introduction

Morayo Adebakin - Digital Events Conference Producer, Informa Connect, UK

8:05am - 8:15am10 mins

Ensuring Diversity and Inclusion in Clinical Trials

Introduction & Self-Reflection exercise

Leonor Ruivo - People Management and EDI officer, Instituto Gulbenkian de Ciência, Portugal

8:15am - 8:45am30 mins

Ensuring Diversity and Inclusion in Clinical Trials

Keynote Speakers - Exploring disability inclusivity to diversify clinical studies

David Dent, MBE - Executive Director, Parexel Biotech, Business Development EU, Parexel Biotech, EU & UK

8:45am - 9:15am30 mins

Ensuring Diversity and Inclusion in Clinical Trials

Category is: LGBTQ+ - the inclusion of a demographic rapidly growing in visibility

Scout (He/Him/They) - Executive Director, National LGBT Cancer Network, USA

9:15am - 9:45am30 mins

Ensuring Diversity and Inclusion in Clinical Trials

Bristol Myers Squibb tackles LGBTQ+ Inclusion

Paul Shay - Global People & Business Resource Group Lead for PRIDE Alliance, Bristol Myers Squibb, USA

9:45am - 10:15am30 mins

Ensuring Diversity and Inclusion in Clinical Trials

Panel Discussion – Exploring problems and solutions surrounding Disability & LGBTQ+ groups' engagement in clinical trials

Scout (He/Him/They) - Executive Director, National LGBT Cancer Network, USA
Rosamund Round - VP, Patient Innovation Center, Parexel International, UK
Jan Kosmyna - Representative, Global Community Advisory Board, & Community Steering Committee, AIDS Clinical Trials Group, USA
Ace Robinson, MHL, MPH, (he/él/il/ele) - Chief Mission Officer, Covid Clinic, USA

10:15am - 10:30am15 mins

Ensuring Diversity and Inclusion in Clinical Trials

Wellness Break & refreshments

10:30am - 11:00am30 mins

Ensuring Diversity and Inclusion in Clinical Trials

Socio-economic background limitations affecting clinical studies

Latha Palaniappan - Professor of Medicine (Primary care and Population health),, Stanford University School of Medicine, USA

11:00am - 11:30am30 mins

Ensuring Diversity and Inclusion in Clinical Trials

Why inclusive language matters in clinical trials

Natasha Ratcliffe, PhD - Director of Community Engagement and Partnerships, COUCH Health, UK

11:30am - 12:00pm30 mins

Ensuring Diversity and Inclusion in Clinical Trials

A Psychological Approach to Increase Diversity and Inclusion in Clinical Trials

Shannon La Cava PsyD - Chief Clinical Officer, Director of Programs and Research, Cancer Support Community Los Angeles, USA

12:00pm - 12:30pm30 mins

Ensuring Diversity and Inclusion in Clinical Trials

Break and networking opportunity

12:30pm - 12:45pm15 mins

Ensuring Diversity and Inclusion in Clinical Trials

Wellness Break & refreshments

12:45pm - 1:15pm30 mins

Ensuring Diversity and Inclusion in Clinical Trials

Clinical Trials: A Rare Disease Patient Perspective

Tasia Rechisky - Patient Advocate and Committee Member, Rare New England, USA

1:15pm - 1:55pm40 mins

Ensuring Diversity and Inclusion in Clinical Trials

Panel Discussion - Addressing Barriers associated with increasing Diversity and Inclusion in Clinical Studies

Wendy Warring, JD - CEO, The Network For Excellence In Health Innovation, USA
CK Wang, MD - Chief Medical Officer, COTA Healthcare, USA
Adrianna Boulin, MPH - Director of Community Impact & Engagement, Fenway Health,USA
James Mayne, PhD - VP Science Advocacy, PhRMA,USA
Maya Zlatanova - CEO and Co-founder, FindMeACure, USA

1:55pm - 2:25pm30 mins

Ensuring Diversity and Inclusion in Clinical Trials

Exploring Decentralised and Virtual trials, with pilot studies and challenges encountered

Michael Zaiac - Head of Medical Affairs Oncology Region Europe, Novartis, Switzerland

2:25pm - 2:30pm5 mins

Ensuring Diversity and Inclusion in Clinical Trials

Conference End and Thank you notes.